| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: E9B4W5
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 8 |
| GO:0005488 | binding | 1 | 8 |
| GO:0036094 | small molecule binding | 2 | 8 |
| GO:0051287 | NAD binding | 4 | 8 |
| GO:0097159 | organic cyclic compound binding | 2 | 8 |
| GO:1901265 | nucleoside phosphate binding | 3 | 8 |
| GO:1901363 | heterocyclic compound binding | 2 | 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 109 | 113 | PF00656 | 0.454 |
| CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.276 |
| CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.415 |
| CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.276 |
| CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.177 |
| CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.304 |
| CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.177 |
| CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.220 |
| CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.340 |
| CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.265 |
| CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.257 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.359 |
| DOC_MAPK_gen_1 | 12 | 21 | PF00069 | 0.589 |
| DOC_MAPK_gen_1 | 58 | 66 | PF00069 | 0.520 |
| DOC_MAPK_MEF2A_6 | 60 | 68 | PF00069 | 0.435 |
| DOC_USP7_UBL2_3 | 12 | 16 | PF12436 | 0.532 |
| DOC_USP7_UBL2_3 | 130 | 134 | PF12436 | 0.275 |
| DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.514 |
| LIG_14-3-3_CanoR_1 | 70 | 75 | PF00244 | 0.468 |
| LIG_AP2alpha_1 | 136 | 140 | PF02296 | 0.330 |
| LIG_APCC_ABBA_1 | 133 | 138 | PF00400 | 0.334 |
| LIG_BRCT_BRCA1_1 | 61 | 65 | PF00533 | 0.558 |
| LIG_FHA_1 | 123 | 129 | PF00498 | 0.411 |
| LIG_FHA_1 | 130 | 136 | PF00498 | 0.402 |
| LIG_LIR_Apic_2 | 105 | 111 | PF02991 | 0.454 |
| LIG_LIR_Gen_1 | 137 | 145 | PF02991 | 0.365 |
| LIG_LIR_Gen_1 | 62 | 72 | PF02991 | 0.455 |
| LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.431 |
| LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.458 |
| LIG_Pex14_2 | 136 | 140 | PF04695 | 0.550 |
| LIG_REV1ctd_RIR_1 | 48 | 57 | PF16727 | 0.476 |
| LIG_UBA3_1 | 55 | 60 | PF00899 | 0.377 |
| LIG_UBA3_1 | 79 | 84 | PF00899 | 0.532 |
| MOD_CK1_1 | 150 | 156 | PF00069 | 0.468 |
| MOD_CK2_1 | 27 | 33 | PF00069 | 0.558 |
| MOD_CK2_1 | 70 | 76 | PF00069 | 0.460 |
| MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.271 |
| MOD_GlcNHglycan | 141 | 146 | PF01048 | 0.337 |
| MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.389 |
| MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.258 |
| MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.276 |
| MOD_GSK3_1 | 118 | 125 | PF00069 | 0.573 |
| MOD_GSK3_1 | 141 | 148 | PF00069 | 0.430 |
| MOD_N-GLC_1 | 122 | 127 | PF02516 | 0.406 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.476 |
| MOD_NEK2_1 | 115 | 120 | PF00069 | 0.568 |
| MOD_NEK2_1 | 27 | 32 | PF00069 | 0.536 |
| MOD_NEK2_1 | 36 | 41 | PF00069 | 0.467 |
| MOD_PK_1 | 70 | 76 | PF00069 | 0.532 |
| MOD_PKA_1 | 84 | 90 | PF00069 | 0.463 |
| MOD_PKA_2 | 6 | 12 | PF00069 | 0.476 |
| MOD_PKA_2 | 84 | 90 | PF00069 | 0.377 |
| MOD_Plk_1 | 27 | 33 | PF00069 | 0.558 |
| MOD_Plk_4 | 36 | 42 | PF00069 | 0.532 |
| MOD_ProDKin_1 | 102 | 108 | PF00069 | 0.514 |
| MOD_SUMO_rev_2 | 109 | 116 | PF00179 | 0.445 |
| MOD_SUMO_rev_2 | 9 | 14 | PF00179 | 0.558 |
| TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.476 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4J7L8 | Bodo saltans | 47% | 100% |
| A0A3R7MNZ9 | Trypanosoma rangeli | 49% | 77% |
| A0A422MS17 | Trypanosoma rangeli | 49% | 99% |
| A0A422MS45 | Trypanosoma rangeli | 57% | 77% |
| A4HAQ6 | Leishmania braziliensis | 71% | 83% |
| A4I9V3 | Leishmania infantum | 69% | 78% |